ETHGas (GWEI) has surged 16% recently, continuing a strong rally that has seen gains of 209% over 90 days and 593% year-to-date. Market data shows a bullish consensus with high trading volumes and a Long/Short Ratio above 1, indicating more buyers than sellers. However, GWEI faces a critical resistance level at $0.125, which it has struggled to surpass, signaling potential hesitation in sustaining the upward momentum. Selling pressure has eased, and accumulation is increasing, but the asset's next move depends on breaking this key resistance to confirm a continued rise.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
